机译:成功治疗Ponatinib用于费城染色体阳性B细胞急性淋巴细胞白血病的中枢神经系统复发
Department of HematologyYokohama Municipal Citizen's HospitalYokohama Japan;
Department of HematologyYokohama Municipal Citizen's HospitalYokohama Japan;
Department of HematologyYokohama Municipal Citizen's HospitalYokohama Japan;
Department of HematologyYokohama Municipal Citizen's HospitalYokohama Japan;
Department of HematologyYokohama Municipal Citizen's HospitalYokohama Japan;
Department of HematologyYokohama Municipal Citizen's HospitalYokohama Japan;
Department of HematologyYokohama Municipal Citizen's HospitalYokohama Japan;
Department of HematologyYokohama Municipal Citizen's HospitalYokohama Japan;
Division of HematologyKeio University School of MedicineTokyo Japan;
机译:成功治疗Ponatinib用于费城染色体阳性B细胞急性淋巴细胞白血病的中枢神经系统复发
机译:帕纳替尼:在成人慢性粒细胞白血病或费城染色体阳性急性淋巴细胞白血病中的应用综述
机译:inotuzumab ozogamicin加ponatinib的功效随后在患有费城染色体阳性急性淋巴细胞白血病患者中的同种异体干细胞移植
机译:一种差分进化算法对急性淋巴细胞白血病图像中白细胞的图像分割
机译:费城染色体阳性的急性淋巴细胞白血病患者的预后因素。
机译:inotuzumab ozogamicin加ponatinib的功效随后在患有费城染色体阳性急性淋巴细胞白血病患者中的同种异体干细胞移植
机译:达沙替尼治疗失败后,费城染色体阳性急性淋巴细胞白血病的英国患者接受PSY53成本效益分析后再进行干细胞移植与最佳支持治疗